Senior Director, Immunology and Translation

Role Overview

• Serve as the primary scientific expert and internal champion for one or more immunology disease areas
• Translate deep mechanistic understanding of immune pathology into actionable therapeutic hypotheses and target identification strategies
• Maintain a current and comprehensive view of the competitive landscape, emerging science, and unmet medical need across assigned disease areas
• Represent CSL Behring at key scientific conferences, advisory boards, and KOL meetings; build and leverage a broad external network of thought leaders, clinical investigators, and academic collaborators
• Drive end-to-end asset progression from ideation through first-in-disease designation, integrating scientific rationale, translational endpoints, patient population selection, and regulatory strategy
• Lead or co-lead target and asset evaluation activities including preclinical data package reviews, mechanism-of-action assessments, and translational feasibility analyses
• Provide scientific input to IND-enabling studies, proof-of-concept study designs, and Phase 1/1b protocol development
• Collaborate with the discovery and translational teams to define disease-relevant biomarkers, pharmacodynamic readouts, and patient stratification strategies for early clinical programs
• Actively contribute to R&D programs as a subject matter expert and provide guidance for the clinical development pathway
• Partner with Business Development to assess in-licensing, partnering, and acquisition opportunities within the immunology space, providing scientific due diligence leadership
• Contribute to Target Product Profiles (TPPs), integrated development plans, and portfolio reviews
• Provide disease area expertise to regulatory submissions, clinical study reports, and scientific communications
• Work collaboratively with Medical Affairs, Clinical Operations, and translational colleagues to align development strategies.

Requirements

• MD, DO, or PhD in Immunology, or a closely related discipline
• 12+ years of experience in drug development within a biotech, pharmaceutical, or academic environment
• Demonstrated experience in preclinical to first-in-disease (or equivalent early clinical milestone) in immunology
• Deep scientific expertise in the immunological mechanisms underpinning autoimmune and inflammatory diseases
• Established and active network in drug development with recognized relationships across rheumatology, neuroimmunology, and/or dermatology communities
• Proven track record in evaluating preclinical and clinical assets, including target assessment, data package review, and go/no-go decision-making
• Strong ability to synthesize complex scientific data and communicate strategy clearly to diverse audiences including senior leadership.

Benefits

• Health insurance
• Professional development opportunities
• Flexible work arrangements
• Bonuses
• Stock options